A detailed history of Rosenberg Matthew Hamilton transactions in Medtronic PLC stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 608 shares of MDT stock, worth $52,415. This represents 0.01% of its overall portfolio holdings.

Number of Shares
608
Previous 608 -0.0%
Holding current value
$52,415
Previous $47,000 14.89%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$82.84 - $88.09 $9,692 - $10,306
-117 Reduced 16.14%
608 $52,000
Q4 2023

Jan 12, 2024

SELL
$69.43 - $83.43 $25,203 - $30,285
-363 Reduced 33.36%
725 $59,000
Q3 2023

Oct 11, 2023

BUY
$78.22 - $90.4 $10,403 - $12,023
133 Added 13.93%
1,088 $85,000
Q2 2023

Jul 26, 2023

SELL
$79.47 - $91.38 $50,622 - $58,209
-637 Reduced 40.01%
955 $84,000
Q4 2022

Jan 18, 2023

SELL
$76.18 - $87.74 $1,828 - $2,105
-24 Reduced 1.49%
1,592 $0
Q3 2022

Oct 21, 2022

BUY
$80.75 - $95.31 $7,106 - $8,387
88 Added 5.76%
1,616 $130,000
Q2 2022

Jul 15, 2022

BUY
$87.4 - $113.09 $21,150 - $27,367
242 Added 18.82%
1,528 $140,000
Q1 2022

Apr 14, 2022

BUY
$100.58 - $112.38 $9,454 - $10,563
94 Added 7.89%
1,286 $143,000
Q4 2021

Jan 20, 2022

SELL
$99.53 - $127.75 $12,341 - $15,841
-124 Reduced 9.42%
1,192 $123,000
Q3 2021

Oct 12, 2021

BUY
$122.75 - $135.17 $15,343 - $16,896
125 Added 10.5%
1,316 $165,000
Q1 2021

Apr 30, 2021

BUY
$111.18 - $119.74 $17,899 - $19,278
161 Added 15.63%
1,191 $141,000
Q4 2020

Feb 03, 2021

BUY
$100.57 - $117.14 $14,381 - $16,751
143 Added 16.12%
1,030 $121,000
Q2 2020

Aug 04, 2020

BUY
$84.11 - $103.33 $8,495 - $10,436
101 Added 12.85%
887 $81,000
Q1 2020

May 14, 2020

BUY
$72.92 - $121.3 $57,315 - $95,341
786 New
786 $71,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Rosenberg Matthew Hamilton Portfolio

Follow Rosenberg Matthew Hamilton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.